Table 2.
Compound | R1 | R2 | PfCDPK1 IC50 (nM) | Pf3D7 IC50 (nM) | In Vivo Parasitemia Reduction 1 |
---|---|---|---|---|---|
5 | 13 | 400 | 46 | ||
6 | 70 | 103 | - | ||
7 | <10 | 12 | 4% | ||
8 | 12 | 80 | 51% |
1 Four-day Peter’s test [27] at an oral dose of 50 mg/kg/day.
Compound | R1 | R2 | PfCDPK1 IC50 (nM) | Pf3D7 IC50 (nM) | In Vivo Parasitemia Reduction 1 |
---|---|---|---|---|---|
5 | 13 | 400 | 46 | ||
6 | 70 | 103 | - | ||
7 | <10 | 12 | 4% | ||
8 | 12 | 80 | 51% |
1 Four-day Peter’s test [27] at an oral dose of 50 mg/kg/day.